Patents matching “The United States of America”

US 8334260

sFRP and peptide motifs that interact with sFRP and methods of their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 18, 2012 · Expires Dec 13, 2032

US 8323706

Antiestrogenic glyceollins suppress human breast and ovarian carcinoma proliferation and tumorigenesis

The United States of America, as represented by the Secretary of Agriculture · Granted Dec 4, 2012 · Expires Nov 29, 2032

US 8323961

HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIV

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 4, 2012 · Expires Nov 29, 2032

US 8318177

Viral chemokine-antigen fusion proteins

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 27, 2012 · Expires Nov 22, 2032

US 8318425

Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein

The United States of America, as Represented by the Secretary, Department of Human Services · Granted Nov 27, 2012 · Expires Nov 22, 2032

US 8318183

Plasmodium liver stage antigens

The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted Nov 27, 2012 · Expires Nov 22, 2032

US 8318666

Use of leptin to treat metabolic abnormalities associated with lipoatrophy

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 27, 2012 · Expires Nov 22, 2032

US 8313746

Human monoclonal antibodies against hendra and nipah viruses

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Nov 20, 2012 · Expires Nov 15, 2032

US 8313789

Methods of promoting the growth of beneficial bacteria in the gut

The United States of America, as represented by the Secretary of Agriculture · Granted Nov 20, 2012 · Expires Nov 15, 2032

US 8309527

Immunomodulatory oligonucleotides

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 13, 2012 · Expires Nov 8, 2032

US 8309701

Variants of human taste receptor genes

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 13, 2012 · Expires Nov 8, 2032

US 8303960

Radiolabeled affibody molecules

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 6, 2012 · Expires Nov 1, 2032

US 8298525

Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 30, 2012 · Expires Oct 25, 2032

US 8299050

Method for treating uterine fibroids

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 30, 2012 · Expires Oct 25, 2032

US 8298546

Isolation and purification of P. falciparum merozoite protein-142 vaccine

The United States of America as represented by the Secretary of the Army · Granted Oct 30, 2012 · Expires Oct 25, 2032

US 8298541

Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 30, 2012 · Expires Oct 25, 2032

US 8293724

Therapeutic applications of fatty acid amide hydrolase inhibitors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 23, 2012 · Expires Oct 18, 2032

US 8293800

Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 23, 2012 · Expires Oct 18, 2032

US 8288439

Methods and compositions for the inhibition of HIV-1 replication

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 16, 2012 · Expires Oct 11, 2032

US 8288530

Method of preparing macromolecular contrast agents and uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Oct 16, 2012 · Expires Oct 11, 2032

US 8287857

Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 16, 2012 · Expires Oct 11, 2032

US 8288359

Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Oct 16, 2012 · Expires Oct 11, 2032

US 8282926

CCR5-specific antibodies with HIV neutralizing activity that recognize a linear dodecapeptide that mimics a conformational epitope in the second extracellular loop of CCR5

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 9, 2012 · Expires Oct 4, 2032

US 8283151

Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 9, 2012 · Expires Oct 4, 2032